NovoCure (NVCR) Tax Rate Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,057.00 |
| Dec 31, 2025 | 5,959.00 |
| Sep 30, 2025 | 1,748.00 |
| Jun 30, 2025 | 3,209.00 |
| Mar 31, 2025 | 921.00 |
| Dec 31, 2024 | 276.00 |
| Sep 30, 2024 | -3,901.00 |
| Jun 30, 2024 | -4,032.00 |
| Mar 31, 2024 | -1,862.00 |
| Dec 31, 2023 | -760.00 |
| Sep 30, 2023 | 1,087.00 |
| Jun 30, 2023 | -373.00 |
| Mar 31, 2023 | 8,089.00 |
| Dec 31, 2022 | -1,111.00 |
| Sep 30, 2022 | 1,111.00 |
| Jun 30, 2022 | 783.00 |
| Mar 31, 2022 | -3,378.00 |
| Dec 31, 2021 | -4,774.00 |
| Sep 30, 2021 | -4,050.00 |
| Jun 30, 2021 | -6,977.00 |
| Mar 31, 2021 | -21,897.00 |
| Dec 31, 2020 | -32,330.00 |
| Sep 30, 2020 | 6,436.00 |
| Jun 30, 2020 | 291,263.00 |
| Mar 31, 2020 | 21,111.00 |
| Dec 31, 2019 | 41,200.00 |
| Sep 30, 2019 | 454.00 |
| Jun 30, 2019 | -279,753.00 |
| Mar 31, 2019 | -2,491.00 |
| Dec 31, 2018 | 1,444.00 |
| Sep 30, 2018 | -1,061.00 |
| Jun 30, 2018 | -3,642.00 |
| Mar 31, 2018 | -415.00 |
| Dec 31, 2017 | -6,121.00 |
| Sep 30, 2017 | -3,197.00 |
| Jun 30, 2017 | -1,208.00 |
| Mar 31, 2017 | -499.00 |
| Dec 31, 2016 | 696.00 |
| Sep 30, 2016 | -653.00 |
| Jun 30, 2016 | -292.00 |
| Mar 31, 2016 | -581.00 |
| Dec 31, 2015 | -419.00 |
| Sep 30, 2015 | -188.00 |